logo
  

Plus Therapeutics Inc. Q1 Loss Decreases, Beats Estimates

Plus Therapeutics Inc. (PSTV) reported Loss for first quarter that decreased from last year and beat the Street estimates.

The company's earnings totaled -$3.26 million, or -$0.75 per share. This compares with -$4.81 million, or -$2.07 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$1.09 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 229.4% to $1.68 million from $0.51 million last year.

Plus Therapeutics Inc. earnings at a glance (GAAP) :

-Earnings (Q1): -$3.26 Mln. vs. -$4.81 Mln. last year.
-EPS (Q1): -$0.75 vs. -$2.07 last year.
-Revenue (Q1): $1.68 Mln vs. $0.51 Mln last year.

For comments and feedback contact: editorial@rttnews.com

The highlight this week was the latest set of first quarter economic growth figures from the U.S. Find out why the data damped the market sentiment. Other main releases from the U.S. included those on consumer confidence and jobless claims. In Europe, German inflation figures caught everyone's attention. Learn why it added to expectations of rate staying “higher for longer”. Asia's economics scene this week was dominated by the release of PMI survey figures from China.

View More Videos
RELATED NEWS
Follow RTT